IFT 0.97% $11.42 infratil limited.

Morrison and Co. out of PRP auction with Crescent wanting...

  1. 1,981 Posts.
    lightbulb Created with Sketch. 291
    Morrison and Co. out of PRP auction with Crescent wanting 12.7-14x EBITDA for the group. Good call I say, plenty of others around on smaller multiples. IDX currently trading on 8.19x and CAJ 8.51x EBITDA.

    As of the AGM (25th August), Infratil had NZ$482.2m in cash, with an addition pending inflow of $510m (Vodafone Towers). RetireAus still up for sale, hoping to realise NZ$550m for that transaction or say NZ$500m post fees, tax etc. Therefore, total available liquidity of NZ$1,492.2m excluding undrawn bank facilities for Infratil.

    IDX and CAJ market caps are AU$612.4m and AU$349.9m respectively. Let's add an additional 20% on each as a takeover premium:
    IDX +20%: AU$734.88M = new EBITDA multiple of 9.82x
    CAJ +20%: AU$419.88M = new EBITDA multiple of 10.22x

    Total consideration from IFT = NZ$1,277.26 (AU$1,154.76). Significantly cheaper than PRP and exposes the trans-tasman diagnostic imaging platform directly into VIC, while consolidating QLD and NSW markets. Post both transactions, Infratil would have avilable liquidity of NZ$214.94 cash + NZ$906.3m in undrawn bank facilities. Enough to seriously consider some battery storage opportunities!

    Cheers,
    Dalto24
    Last edited by dalto24: 18/09/22
 
watchlist Created with Sketch. Add IFT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.